NHS vs MSFT: Which Stock is Better?

Side-by-side comparison of Neuberger Berman High Yield Strategies Fund Inc. and Microsoft Corp in 2026

Comparison Updated:

NHS

Neuberger Berman High Yield Strategies Fund Inc.

$7.51

MSFT

Microsoft Corp

$403.96

Key Metrics Comparison

MetricNHSMSFTWinner
Market CapN/AN/ATie
P/E RatioN/A36.30MSFT
EPS (TTM)$N/A$13.70MSFT
Revenue Growth0.0%14.9%MSFT
Gross Margin0.0%68.8%MSFT

Analyze NHS

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is NHS or MSFT a better investment?

Comparing NHS and MSFT: Neuberger Berman High Yield Strategies Fund Inc. has a market cap of N/A while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between NHS and MSFT?

NHS (Neuberger Berman High Yield Strategies Fund Inc.) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: NHS or MSFT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: NHS or MSFT?

MSFT has higher revenue growth at 14.9% vs 0.0% for NHS.

Which company is more profitable: NHS or MSFT?

Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 0.0% for NHS.

Which is the larger company: NHS or MSFT?

Microsoft Corp (MSFT) is larger with a market cap of N/A compared to N/A for NHS.

Should I buy NHS or MSFT in 2026?

Both NHS and MSFT have investment merit. NHS trades at $7.51 while MSFT trades at $403.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between NHS and MSFT stock?

Key differences: Market Cap (N/A vs N/A), P/E Ratio (N/A vs 36.3x), Revenue Growth (0.0% vs 14.9%), Gross Margin (0.0% vs 68.8%).

Popular Stock Comparisons